Plasm N-terminal pro-B-type natriaretic peptide (NT-proBNP) levels and severity of coronary artery lesions in patients with acute coronary syndrome

Yang Shuguang,Wang Aiping,Tang Xuechao

DOI: https://doi.org/10.3321/j.issn:0577-7402.2007.11.024

2007-01-01

Medical Journal of Chinese People's Liberation Army

Abstract:Objective To investigate the relationship between plasm N-terminal pro-B-type natriuretic peptide(NT-proBNP) levels and severity of coronary artery disease and coronary artery lesions. Methods 150 patients complaining of chest pain and suspected to have coronary artery disease (CAD) were enrolled in the study. Plasm NT-proBNP contents were determined with ELISA method within 48h, and left ventricular ejection fraction (LVEF) was assessed with echocardiography 5-7 days after admission. All patients underwent coronary artery angiography(CAG) 2-17 days after admission and the severity of coronary artery lesions was estimated by coronary angiographic Gensini scores. According to the clinical data and results of CAG, 78 patients were diagnosed as acute coronary syndromes (ACS), 33 patients as stable angina, and 39 patients in whom angiography showed negative findings, served as normal controls. The correlation of plasm NT-proBNP levels with clinical severity of coronary artery disease and Gensini scores were analysed. Results Plasm NT-proBNP levels in patients with ACS, stable angina and in normal controlls were 526.96±376.90, 95.61±56.32 and 41.75±24.26pg/ml,respectively(P<0.05). The Gensini Scores of CAG in patients with ACS, stable angina and in normal controlls were 44.52±29.10, 9.27±2.96 and 0,respectively (P<0.01). Plasm NT-ProBNP levels in patients with left main cronary disease was increased compared with that in patients with 1, 2, or 3 coronary vessels disease. Plasm NT-ProBNP levels were positively correlated with the Gensini Scores of CAG in all patients (P=0.0001) and negatively correlated with LVEF in patients with ACS (P=0.0001). Conclusion Plasm NT-proBNP levels is correlated with the clinical severity of CAD and angiographic cornary artery lensions in patients with ACS, therefore it can be used as a biochemical marker for risk stratification in patients with CAD.